Can Amoxicillin/Clavulanate Tablets Be Split?
No, amoxicillin/clavulanate tablets should not be split, even if the patient consumes both halves. The FDA-approved formulations, particularly the extended-release adult formulation, use a modified-release mechanism that would be disrupted by splitting, potentially causing altered drug release and dosing errors 1.
Why Splitting Is Problematic
Modified-Release Formulation Issues
The adult formulation of high-dose amoxicillin/clavulanate specifically uses a modified-release mechanism to provide pharmacokinetically enhanced drug delivery 1. Splitting this tablet would:
- Destroy the controlled-release properties
- Lead to potentially rapid, uncontrolled drug release
- Result in unpredictable blood levels that could compromise efficacy or increase adverse effects
Dose Accuracy Concerns
Research demonstrates that tablet splitting produces significant weight and dose variability 2, 3, 4:
- Even with splitting devices, substantial deviations from theoretical weight occur
- Manual splitting methods (scissors, knives) produce even greater variability
- Weight loss during splitting can be substantial
- For medications requiring precise dosing, these variations are clinically significant
Physical Challenges
Many patients, particularly elderly individuals, struggle to split tablets effectively 2, 5:
- The majority of elderly patients cannot break tablets properly without assistance
- Physical limitations affect splitting accuracy
- Patient confusion can lead to medication errors
Alternative Solutions
Use Appropriate Formulations
Switch to the oral suspension formulation 6:
- Amoxicillin/clavulanate oral suspension (600 mg/42.9 mg per 5 mL) is specifically designed for patients who cannot swallow tablets
- Provides accurate dosing without splitting concerns
- FDA-approved for pediatric patients but can be considered for adults with swallowing difficulties
Consider Different Tablet Strengths
If suspension is not suitable, prescribe a lower-strength tablet that the patient can swallow whole, adjusting the number of tablets to achieve the correct total daily dose.
Important Caveat
The FDA label explicitly states: "Adults who have difficulty swallowing should not be given Amoxicillin and Clavulanate Potassium for Oral Suspension (600 mg/42.9 mg per 5 mL) in place of the 500 mg/125 mg or 875 mg/125 mg tablet" 6. However, this refers to substitution without proper dosing adjustment—the suspension itself remains the appropriate formulation for swallowing difficulties.
Clinical Bottom Line
Do not split amoxicillin/clavulanate tablets. Instead, prescribe the oral suspension formulation for patients unable to swallow large tablets. This ensures accurate dosing, maintains the intended pharmacokinetic profile, and avoids the risks associated with tablet splitting 6, 2, 7.